Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Opioid Avoidance Protocol for ACL Reconstruction Surgery

NCT06340932 is registered in ClinicalTrials.gov with Matthew Varacallo as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06340932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Opioid Avoidance Protocol for ACL Reconstruction Surgery
Lead sponsor
Matthew Varacallo
Phase
Observational
Overall status
Completed
Start date
April 27, 2024
Completion date
February 1, 2025
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acl tear, post operative pain